Hydroxychloroquine Sulfate Tablets
Sponsors
First Affiliated Hospital Xi'an Jiaotong University, Cardresearch, National University Hospital, Singapore, Shanghai First Maternity and Infant Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions
Acute Respiratory InfectionAntiphospholipid SyndromeCOVID-19Coronary Artery DiseaseCoronavirus InfectionCovid-19Primary Sjögren's SyndromeRadiation-induced Oral Mucositis
Phase 1
Phase 3
Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: The Hope Coalition - 1
NCT04403100
Start: 2020-06-03End: 2021-02-01Target: 1968Updated: 2021-01-26
A Preventive Treatment for Migrant Workers at High-risk of COVID-19
CompletedNCT04446104
Start: 2020-05-13End: 2020-08-31Updated: 2020-10-19
Phase 4
Efficacy Study of Hydroxychloroquine to Treat High-risk Coronary Artery Disease.
CompletedNCT02874287
Start: 2017-10-08End: 2019-06-01Updated: 2021-08-27
A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome
NCT04624269
Start: 2020-12-01End: 2023-02-01Target: 384Updated: 2020-11-10
The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
RecruitingNCT04981145
Start: 2022-01-14End: 2025-07-31Target: 78Updated: 2024-10-16